|
1
|
Cao SM, Simons MJ and Qian CN: The
prevalence and prevention of nasopharyngeal carcinoma in China.
Chin J Cancer. 30:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng X, Ren C, Zhou W, Liu W, Zeng L, Li
G, Wang L, Li M, Zhu B, Yao K and Jiang X: Promoter
hypermethylation along with LOH, but not mutation, contributes to
inactivation of DLC-1 in nasopharyngeal carcinoma. Mol Carcinog.
53:858–870. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stoker SD, van Diessen JN, de Boer JP,
Karakullukcu B, Leemans CR and Tan IB: Current treatment options
for local residual nasopharyngeal carcinoma. Curr Treat Options
Oncol. 14:475–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Chen QY, Liu H, Tang LQ and Mai
HQ: Emerging treatment options for nasopharyngeal carcinoma. Drug
Des Devel Ther. 7:37–52. 2013.PubMed/NCBI
|
|
5
|
Colaco RJ, Betts G, Donne A, Swindell R,
Yap BK, Sykes AJ, Slevin NJ, Homer JJ and Lee LW: Nasopharyngeal
carcinoma: A retrospective review of demographics, treatment and
patient outcome in a single centre. Clin Oncol (R Coll Radiol).
25:171–177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Falkenberg KJ and Johnstone RW: Histone
deacetylases and their inhibitors in cancer, neurological diseases
and immune disorders. Nat Rev Drug Discov. 13:673–691. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun DP, Li XX, Liu XL, Zhao D, Qiu FQ, Li
Y and Ma P: Gypenosides induce apoptosis by ca2+ overload mediated
by endoplasmic-reticulum and store-operated ca2+ channels in human
hepatoma cells. Cancer Biother Radiopharm. 28:320–326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
West AC and Johnstone RW: New and emerging
HDAC inhibitors for cancer treatment. J Clin Invest. 124:30–39.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goncalves P and Martel F: Butyrate and
colorectal cancer: The role of butyrate transport. Curr Drug Metab.
14:994–1008. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tailor D, Hahm ER, Kale RK, Singh SV and
Singh RP: Sodium butyrate induces DRP1-mediated mitochondrial
fusion and apoptosis in human colorectal cancer cells.
Mitochondrion. 16:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei ZL, Zhao QL, Yu DY, Hassan MA, Nomura
T and Kondo T: Enhancement of sodium butyrate-induced cell death
and apoptosis by X-irradiation in the human colorectal cancer cell
line HCT 116. Oncol Rep. 20:397–403. 2008.PubMed/NCBI
|
|
12
|
Prevarskaya N, OuadidAhidouch H, Skryma R
and Shuba Y: Remodelling of Ca2+ transport in cancer: How it
contributes to cancer hallmarks? Philos Trans R Soc Lond B Biol
Sci. 369:201300972014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen YF, Chen YT, Chiu WT and Shen MR:
Remodeling of calcium signaling in tumor progression. J Biomed Sci.
20:232013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bergmeier W, Weidinger C, Zee I and Feske
S: Emerging roles of store-operated Ca2+ entry through
STIM and ORAI proteins in immunity, hemostasis and cancer. Channels
(Austin). 7:379–391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiu WT, Tang MJ, Jao HC and Shen MR: Soft
substrate up-regulates the interaction of STIM1 with store-operated
Ca2+ channels that lead to normal epithelial cell apoptosis. Mol
Biol Cell. 19:2220–2230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Flourakis M, Lehen'kyi V, Beck B, Raphaël
M, Vandenberghe M, Abeele FV, Roudbaraki M, Lepage G, Mauroy B,
Romanin C, et al: Orai1 contributes to the establishment of an
apoptosis-resistant phenotype in prostate cancer cells. Cell Death
Dis. 1:e752010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun S, Li W, Zhang H, Zha L, Xue Y, Wu X
and Zou F: Requirement for store-operated calcium entry in sodium
butyrate-induced apoptosis in human colon cancer cells. Biosci Rep.
32:83–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang S, Zhang JJ and Huang XY: Orai1 and
STIM1 are critical for breast tumor cell migration and metastasis.
Cancer Cell. 15:124–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng X, Li C, Liu W, Chen H, Zhou W, Wang
L, Zhu B, Yao K, Jiang X and Ren C: DLC-1, a candidate tumor
suppressor gene, inhibits the proliferation, migration and
tumorigenicity of human nasopharyngeal carcinoma cells. Int J
Oncol. 42:1973–1984. 2013.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paskova L, Trtkova K Smesny, Fialova B,
Benedikova A, Langova K and Kolar Z: Different effect of sodium
butyrate on cancer and normal prostate cells. Toxicol in vitro.
27:1489–1495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maruyama T, Yamamoto S, Qiu J, Ueda Y,
Suzuki T, Nojima M and Shima H: Apoptosis of bladder cancer by
sodium butyrate and cisplatin. J Infect Chemother. 18:288–295.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mu D, Gao Z, Guo H, Zhou G and Sun B:
Sodium butyrate induces growth inhibition and apoptosis in human
prostate cancer DU145 cells by up-regulation of the expression of
annexin A1. PloS One. 8:e749222013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weichert W, Röske A, Gekeler V, Beckers T,
Stephan C, Jung K, Fritzsche FR, Niesporek S, Denkert C, Dietel M
and Kristiansen G: Histone deacetylases 1, 2 and 3 are highly
expressed in prostate cancer and HDAC2 expression is associated
with shorter PSA relapse time after radical prostatectomy. Br J
Cancer. 98:604–610. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weichert W, Röske A, Niesporek S, Noske A,
Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T and Denkert
C: Class I histone deacetylase expression has independent
prognostic impact in human colorectal cancer: Specific role of
class I histone deacetylases in vitro and in vivo. Clin Cancer Res.
14:1669–1677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krusche CA, Wülfing P, Kersting C, Vloet
A, Böcker W, Kiesel L, Beier HM and Alfer J: Histone deacetylase-1
and −3 protein expression in human breast cancer: A tissue
microarray analysis. Breast Cancer Res Treat. 90:15–23. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun B, Liu R, Xiao ZD and Zhu X: c-MET
protects breast cancer cells from apoptosis induced by sodium
butyrate. PloS One. 7:e301432012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He YW, Wang HS, Zeng J, Fang X, Chen HY,
Du J and Yang XY: Sodium butyrate inhibits interferon-gamma induced
indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal
carcinoma cells. Life sci. 93:509–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gospodinov A, Popova S, Vassileva I and
Anachkova B: The inhibitor of histone deacetylases sodium butyrate
enhances the cytotoxicity of mitomycin C. Mol Cancer Ther.
11:2116–2126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pinton P, Giorgi C, Siviero R, Zecchini E
and Rizzuto R: Calcium and apoptosis: ER-mitochondria Ca2+ transfer
in the control of apoptosis. Oncogene. 27:6407–6418. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rizzuto R, Pinton P, Ferrari D, Chami M,
Szabadkai G, Magalhães PJ, Di Virgilio F and Pozzan T: Calcium and
apoptosis: Facts and hypotheses. Oncogene. 22:8619–8627. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Prevarskaya N, Skryma R and Shuba Y:
Targeting Ca2+ transport in cancer: Close reality or long
perspective? Expert Opin Ther Targets. 17:225–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schmidt S, Liu G, Liu G, Yang W, Honisch
S, Pantelakos S, Stournaras C, Hönig A and Lang F: Enhanced Orai1
and STIM1 expression as well as store operated Ca2+ entry in
therapy resistant ovary carcinoma cells. Oncotarget. 5:4799–4810.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kondratska K, Kondratskyi A, Yassine M,
Lemonnier L, Lepage G, Morabito A, Skryma R and Prevarskaya N:
Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance
of pancreatic adenocarcinoma. Biochim Biophys Acta. 1843:2263–2269.
2014. View Article : Google Scholar : PubMed/NCBI
|
